https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-11-01 / J. Immunother. 2004 Nov-Dec;27(6):452-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-11-01 / J. Immunother. 2004 Nov-Dec;27(6):452-92004-11-01 00:00:002019-02-15 08:46:58Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-622004-11-01 00:00:002021-11-15 15:38:39Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-27 / J. Clin. Oncol. 2004 Nov;22(21):4272-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-27 / J. Clin. Oncol. 2004 Nov;22(21):4272-812004-09-27 00:00:002020-06-23 09:41:00Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-262004-08-15 00:00:002019-02-15 08:47:00Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-07-15 / Cancer Res. 2004 Jul;64(14):4973-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-07-15 / Cancer Res. 2004 Jul;64(14):4973-92004-07-15 00:00:002019-02-15 08:47:00Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-72004-05-01 00:00:002021-11-15 15:38:16Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / J. Neurooncol. 2004 Mar-Apr;67(1-2):83-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / J. Neurooncol. 2004 Mar-Apr;67(1-2):83-932004-03-01 00:00:002019-02-15 09:00:18MTH-68/H oncolytic viral treatment in human high-grade gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-10-06 / Br. J. Cancer 2003 Oct;89(7):1172-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-10-06 / Br. J. Cancer 2003 Oct;89(7):1172-92003-10-06 00:00:002019-02-15 08:47:01Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-08-01 / J. Neurooncol. 2003 Aug-Sep;64(1-2):161-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-08-01 / J. Neurooncol. 2003 Aug-Sep;64(1-2):161-762003-08-01 00:00:002019-02-15 08:34:55The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-932002-07-01 00:00:002020-06-23 09:44:19Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
